Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary

Journal of Medical Microbiology

Volumn 49, Issue 5, 2000, Pages 427-430

  Soki J ^a   Urban, E ^a   Szoke I ^a   Fodor, E ^a   Nagy, E ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM; IMIPENEM; MEMBRANE PROTEIN; MEROPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BACTEROIDES; BACTEROIDES FRAGILIS; CONTROLLED STUDY; FECES MICROFLORA; GENETIC ANALYSIS; HUNGARY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

BACTEROIDES; BACTEROIDES FRAGILIS;

EID: 0034020055     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-5-427     Document Type: Article

References (20)

1. 1. Finegold SM, Lance GW. Anaerobic infections in humans. San Diego, Academic Press. 1989.
2. 2. Dubreuil L, Derriennic M, Sedallian A, Romond C, Courtieu AL. Evaluation of antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys. Infection 1989; 17: 197-200.
3. 3. Phillips I, King A, Nord CE, Hoffstedt B. Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group. Eur J Clin Microbiol Infect Dis 1992; 11: 292-304.
4. 4. Nord CE, Hedberg M. Resistance to beta-lactam antibiotics in anaerobic bacteria. Rev Infect Dis 1990; 12 Suppl 2: S231-S234.
5. 5. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-584.
6. 6. Podglajen I, Breuil J, Casin I, Collatz E. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol 1995; 177: 5270-5275.
7. 7. Edwards R, Thirlwell D, Greenwood D. Changes in beta-lactam antibiotic susceptibility and beta-lactamase production of clinical isolates of Bacteroides and Prevotella species over a 9 year period. J Antimicrob Chemother 1996; 37: 636-638.
8. 8. Podglajen I, Breuil J, Bordon F, Gutmann L, Collatz E. A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutation. FEMS Microbiol Lett 1992; 91: 21-30.
9. 9. Edwards R, Hawkyard CJ, Garvey MT, Greenwood D. Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. J Antimicrob Chemother 1999; 43: 273-276.
10. 10. Nagy E, Szöke I, Gacs M, Csiszár K. Antibiotic susceptibility of Bacteroides fragilis group strains in Hungary. Anaerobe 1995; 1: 269-274.
11. 11. Kesado T, Lindqvist L, Hedberg M, Tunér K, Nord CE. Purification and characterization of a new beta-lactamase from Clostridium butyricum. Antimicrob Agents Chemother 1989; 33: 1302-1307.
12. 12. Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO. Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 1986; 24: 330-332.
13. 13. National Committee for Clinical Laboratory Standards. Interpretative categories and correlative minimum inhibitory concentrations (MICs), 4th edn. Document M11-A4. NCCLS. 1997.
14. 14. Edwards R, Greenwood D. Outer membrane analysis of B. fragilis strains with reduced susceptibility to imipenem. In: Duerden BI, Wade WG, Brazier JS, Eley A, Wren B, Hudson MJ (eds) Medical and dental aspects of anaerobes. Northwood, Middlesex, Science Reviews. 1995: 307-309.
15. 15. Nagy E, Szöke I, Gacs M, Csiszár K. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains. Acta Microbiol Immunol Hung 1995; 42: 287-299.
16. 16. Wexler HM, Finegold SM. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother 1988; 32: 403-406.
17. 17. Bandoh K, Ueno K, Watanabe K, Kato N. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Clin Infect Dis 1993; 16 Suppl 4: S382-S386.
18. 18. Podglajen I, Breuil J, Collatz E. Insertion of a novel DNA sequence, IS1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol Microbiol 1994; 12: 105-114.
19. 19. Fang H, Edlund C, Hedberg M. Detection of imipenem resistant and metronidazole resistant Bacteroides fragilis group strains in faecal samples. Clin Microbiol Infect (in press).
20. 20. Podglajen I, Breuil J, Rybkine T, Collatz E. Emergence of cfiA-mediated carbapenem resistance in Bacteroides distasonis. Program and Abstracts of the 38th ICCAC. Washington, DC, ASM Press. 1998: 118.